in vitro News and Research

RSS
Hybrid immunity shown to offer sub-optimal protection against SARS-CoV-2 Omicron variant

Hybrid immunity shown to offer sub-optimal protection against SARS-CoV-2 Omicron variant

SARS-CoV-2 shown to spread through cell-to-cell transmission

SARS-CoV-2 shown to spread through cell-to-cell transmission

SARS-CoV-2 spike engagement of ACE2 shown to prime S2′ site cleavage and fusion initiation

SARS-CoV-2 spike engagement of ACE2 shown to prime S2′ site cleavage and fusion initiation

New lab-on-a-chip platform for detecting SARS-CoV-2 in resource-limited settings

New lab-on-a-chip platform for detecting SARS-CoV-2 in resource-limited settings

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

Bolstering current therapeutic antibody treatments to help fight Omicron infections

Bolstering current therapeutic antibody treatments to help fight Omicron infections

Lab engineered human A549 lung cell model conducive for investigating SARS-CoV-2 antivirals

Lab engineered human A549 lung cell model conducive for investigating SARS-CoV-2 antivirals

Dual-receptors help widespread dissemination of SARS-CoV-2

Dual-receptors help widespread dissemination of SARS-CoV-2

Study provides deeper insights into familial Alzheimer's disease pathogenesis

Study provides deeper insights into familial Alzheimer's disease pathogenesis

Researchers isolate Omicron variant, leveling the path to vaccine development and vaccine efficacy studies

Researchers isolate Omicron variant, leveling the path to vaccine development and vaccine efficacy studies

Anti-fogging sprays and cloths may contain high levels of PFAS, finds study

Anti-fogging sprays and cloths may contain high levels of PFAS, finds study

Oral bacteria-based SARS-CoV-2 vaccine platform

Oral bacteria-based SARS-CoV-2 vaccine platform

Experts cautiously optimistic about risks of Delta-Omicron mutations mix

Experts cautiously optimistic about risks of Delta-Omicron mutations mix

Efficacy of antibodies induced by natural infection, vaccination, or both against SARS-CoV-2 Omicron and Beta variants

Efficacy of antibodies induced by natural infection, vaccination, or both against SARS-CoV-2 Omicron and Beta variants

In vitro effect of several antiviral drugs against various SARS-CoV-2 variants of concern

In vitro effect of several antiviral drugs against various SARS-CoV-2 variants of concern

Siemens Healthineers Announces FDA Emergency Use Authorization for CLINITEST® Rapid COVID-19 Antigen Self-Test

Siemens Healthineers Announces FDA Emergency Use Authorization for CLINITEST® Rapid COVID-19 Antigen Self-Test

T-cell responses to SARS-CoV-2 Omicron variant confer protection to vaccinated individuals

T-cell responses to SARS-CoV-2 Omicron variant confer protection to vaccinated individuals

Humanized antibody shows strong neutralization ability against SARS-CoV-2 Delta variant

Humanized antibody shows strong neutralization ability against SARS-CoV-2 Delta variant

Echinacea, a potent antiviral against SARS-CoV-2

Echinacea, a potent antiviral against SARS-CoV-2

P323L mutations in SARS-CoV-2 are highly predictive of the emergence of new variants

P323L mutations in SARS-CoV-2 are highly predictive of the emergence of new variants